These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 546349)

  • 1. [MRS (Monitored Release Studies): study of a drug in real life].
    Peris A; Daufi L; Masriera JM
    Arch Farmacol Toxicol; 1979 Dec; 5(3):247-8. PubMed ID: 546349
    [No Abstract]   [Full Text] [Related]  

  • 2. [Critical study of methods of postmarketing drug surveillance].
    Gut JP; Auriche M; Spriet-Pourra C; Juillet Y
    Therapie; 1985; 40(5):313-9. PubMed ID: 3913048
    [No Abstract]   [Full Text] [Related]  

  • 3. Adverse drug reaction reporting.
    Bosco LA
    Am J Gastroenterol; 1987 Apr; 82(4):356-7. PubMed ID: 3565343
    [No Abstract]   [Full Text] [Related]  

  • 4. [How to report side-effects of drugs?].
    Guillaume JC
    Ann Dermatol Venereol; 1986; 113(4):375-6. PubMed ID: 3767239
    [No Abstract]   [Full Text] [Related]  

  • 5. [Sensitivity and specificity of imputability criteria. Study and comparison of these efficacity indices for 7 methods].
    Péré JC; Godin MH; Bégaud B; Haramburu F; Albin H
    Therapie; 1985; 40(5):307-12. PubMed ID: 4095687
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug surveillance. Which methods? For which adverse effects? Application to teratogen monitoring].
    Goujard J
    Therapie; 1985; 40(5):287-92. PubMed ID: 4095683
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bayesian approach to the imputability of undesirable phenomena to drugs].
    Auriche M
    Therapie; 1985; 40(5):301-6. PubMed ID: 4095686
    [No Abstract]   [Full Text] [Related]  

  • 8. [A network of regional correspondents for studying undesirable effects].
    Haramburu F; Péré JC; Begaud B; Albin H
    Therapie; 1985; 40(5):321-4. PubMed ID: 4095688
    [No Abstract]   [Full Text] [Related]  

  • 9. Adverse drug reaction reporting system: developing a well-monitored program.
    Kilarski DJ; Ziegler B; Coarse J; Buchanan C
    Hosp Formul; 1986 Sep; 21(9):949-52. PubMed ID: 10289704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug surveillance in patients of advanced-age].
    Bol Oficina Sanit Panam; 1984 Apr; 96(4):342-52. PubMed ID: 6233994
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drug by drug imputation of adverse effects in drug monitoring. Attempted comparison of different methods].
    Lagier G; Vincens M; Lefebure B; Frelon JH
    Therapie; 1983; 38(3):295-302. PubMed ID: 6612666
    [No Abstract]   [Full Text] [Related]  

  • 12. [Adverse reactions to drugs in gastroenterological patients during their hospitalization].
    Naranjo CA; Sanhueza P
    Rev Med Chil; 1973 Jun; 101(6):456-63. PubMed ID: 4764561
    [No Abstract]   [Full Text] [Related]  

  • 13. Postmarketing surveillance.
    Oleen MA
    Can J Hosp Pharm; 1987 Oct; 40(5):171-2, 179-80. PubMed ID: 10284449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceutical services to improve drug therapy for home health care patients.
    Solomon DK; Baumgartner RP; Weissman AM; Briscoe ME; Smith RM; McCormick WC
    Am J Hosp Pharm; 1978 May; 35(5):553-7. PubMed ID: 655176
    [No Abstract]   [Full Text] [Related]  

  • 15. Methods in monitoring. A review of techniques of drug surveillance.
    Powell C
    Gerontol Clin (Basel); 1974; 16(1):112-7. PubMed ID: 4604766
    [No Abstract]   [Full Text] [Related]  

  • 16. Adverse drug reaction reporting: a working system.
    Michelson PA; Shields K
    Hosp Pharm; 1987 Jul; 22(7):682-4. PubMed ID: 10282685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parenteral and enteral nutrition in the 80s: Part I. Pharmacologic interventions in patients requiring nutritional support.
    Mirtallo JM; Schneider PJ; Fabri PJ
    Hosp Formul; 1982 Apr; 17(4):545-9. PubMed ID: 10309582
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial: The confusions and consolations of uncertainty.
    Ingelfinger FJ
    N Engl J Med; 1975 Jun; 292(26):1402-3. PubMed ID: 1138171
    [No Abstract]   [Full Text] [Related]  

  • 19. Implementing randomization.
    Roos LL; Roos NP; McKinley B
    Policy Anal; 1977; 3(4):547-59. PubMed ID: 10236552
    [No Abstract]   [Full Text] [Related]  

  • 20. [Gleanings from clinical pharmacology].
    Káldor A
    Orv Hetil; 1988 Mar; 129(10):483-6. PubMed ID: 3283638
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.